Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
S
Synmosa Biopharma Corp
TPEX:4114
Synmosa Biopharma Corp
TPEX:4114
Price:
29.05
TWD
Market Closed
Market Cap:
NT$16B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Synmosa Biopharma Corp
TPEX:4114
|
TW |
|
W
|
We&Win Diversification Co Ltd
TPEX:4113
|
TW |
|
W
|
WiseChip Semiconductor Inc
TPEX:5245
|
TW |
|
M
|
Mildef Crete Inc
TPEX:3213
|
TW |
|
S
|
Suntrust Resort Holdings Inc
XPHS:SUN
|
PH |
|
M
|
Manila Mining Corp
XPHS:MA
|
PH |
|
S
|
Shifa International Hospitals Ltd
KAR:SHFA
|
PK |
|
Miramar Resources Ltd
ASX:M2R
|
AU |
|
B
|
Bell Copper Corp
OTC:BCUFF
|
CA |
|
Leonardo DRS Inc
NASDAQ:DRS
|
US |
|
S
|
Sungchang Autotech Co Ltd
KOSDAQ:080470
|
KR |
|
PVA TePla AG
OTC:TPLKF
|
DE |
|
P
|
Public Power Corporation SA
DUS:PU8
|
GR |
|
H
|
Haseeb Waqas Sugar Mills Ltd
KAR:HWQS
|
PK |
|
Nexans SA
F:NXS
|
FR |
|
B
|
Bloomios Inc
OTC:BLMS
|
US |
|
Vale Indonesia Tbk PT
OTC:PTNDF
|
ID |
|
First Resources Ltd
F:5F1
|
SG |
|
P
|
Punjab & Sind Bank
BSE:533295
|
IN |
|
S
|
Sitara Chemical Industries Ltd
KAR:SITC
|
PK |
|
P
|
PT Indo American Seafoods Tbk
IDX:ISEA
|
ID |
|
M
|
MREIT Inc
XPHS:MREIT
|
PH |
|
S
|
Solid Group Inc
XPHS:SGI
|
PH |
|
F
|
Faran Sugar Mills Ltd
KAR:FRSM
|
PK |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Synmosa Biopharma Corp's stock price target?
Not Available
Synmosa Biopharma Corp does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Synmosa Biopharma Corp?
Projected CAGR
13%
13%
Over the last 13 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 1 year is 13%.
What is the Gross Profit forecast for Synmosa Biopharma Corp?
Projected CAGR
14%
14%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 13%. The projected CAGR for the next 1 year is 14%.
What is the Operating Income forecast for Synmosa Biopharma Corp?
Projected CAGR
19%
19%
Over the last 13 years, the compound annual growth rate for Operating Income has been 39%. The projected CAGR for the next 1 year is 19%.
What is the Pre-Tax Income forecast for Synmosa Biopharma Corp?
Projected CAGR
17%
17%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 18%. The projected CAGR for the next 1 year is 17%.
What is the Net Income forecast for Synmosa Biopharma Corp?
Projected CAGR
16%
16%
Over the last 13 years, the compound annual growth rate for Net Income has been 18%. The projected CAGR for the next 1 year is 16%.